Choose an option to locate/access this article: Choose an option to locate/access this article: Choose an option to locate/access this article: Choose an option to locate/access this article: Abstract Aims Angiotensin-converting enzyme (ACE) inhibitors are used in diabetic kidney disease to reduce systemic/intra-glomerular pressure. The objective of this study was to investigate whether reducing blood pressure (BP) could modulate renal glucose transporter expression, and urinary markers of diabetic nephropathy in diabetic hypertensive rats treated with ramipril or amlodipine.
